-

Trinity Life Sciences Offers Digital Approach to Understanding the Patient Journey

The Solution Leverages Multiple Online Research Modalities to Deliver Valuable Insights on the Patient Experience

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announces the availability of Trinity EthnoCapture, a digital approach to understanding the patient journey. The full-service solution uses multiple online tools (including digital diaries, online bulletin boards, online messaging discussions and archetyping) to uncover deep insights into patients’ clinical and emotional experiences.

One of the reasons digital ethnography is becoming more desirable is because healthcare providers are becoming less easy to recruit in person and on the phone. According to a recent TGaS Advisor’s survey (a division of Trinity), biopharmaceutical companies have challenges with healthcare providers (HCPs) traveling to central locations for research and being too busy to contact by phone for recruitment.

“HCPs may be less available to participate in research due to enhanced demands on their time driven by COVID-19 and an overall desire to avoid face-to-face interactions. This presents an opportunity for organizations to focus research efforts on patients. We expect patients to have their health top-of-mind over the coming months and be willing to open up about their experiences,” said Jennifer Parr, Head of Patient Centricity, Trinity. “Trinity’s EthnoCapture with its unique, online multi-modal approach is well-suited for this environment, providing patients with a way to share their perspective and experience without leaving their homes.”

Trinity EthnoCapture offers benefits over traditional ethnography and face-to-face interviews. The depth and scope of data that can be collected using digital methods can often be more meaningful:

  • Deep and thorough -- Patients can complete the exercises on their own time, allowing their story to come together over time and in more detail.
  • Latent emotions and motivations -- Patients can express themselves through methods other than spoken word– often imagery suggests emotions and motivations that are not top of mind during an interview.
  • Reduces burden on the patient -- Asynchronous discussions allow respondents to interact at their own pace making it easier for patients with busy lives to participate.

About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom